Literature DB >> 22532695

Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation.

Laurence Josset1, Jessica A Belser, Mary J Pantin-Jackwood, Jean H Chang, Stewart T Chang, Sarah E Belisle, Terrence M Tumpey, Michael G Katze.   

Abstract

While pandemic 2009 H1N1 influenza A viruses were responsible for numerous severe infections in humans, these viruses do not typically cause corresponding severe disease in mammalian models. However, the generation of a virulent 2009 H1N1 virus following serial lung passage in mice has allowed for the modeling of human lung pathology in this species. Genetic determinants of mouse-adapted 2009 H1N1 viral pathogenicity have been identified, but the molecular and signaling characteristics of the host response following infection with this adapted virus have not been described. Here we compared the gene expression response following infection of mice with A/CA/04/2009 (CA/04) or the virulent mouse-adapted strain (MA-CA/04). Microarray analysis revealed that increased pathogenicity of MA-CA/04 was associated with the following: (i) an early and sustained inflammatory and interferon response that could be driven in part by interferon regulatory factors (IRFs) and increased NF-κB activation, as well as inhibition of the negative regulator TRIM24, (ii) early and persistent infiltration of immune cells, including inflammatory macrophages, and (iii) the absence of activation of lipid metabolism later in infection, which may be mediated by inhibition of nuclear receptors, including PPARG and HNF1A and -4A, with proinflammatory consequences. Further investigation of these signatures in the host response to other H1N1 viruses of various pathogenicities confirmed their general relevance for virulence of influenza virus and suggested that lung response to MA-CA/04 virus was similar to that following infection with lethal H1N1 r1918 influenza virus. This study links differential activation of IRFs, nuclear receptors, and macrophage infiltration with influenza virulence in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532695      PMCID: PMC3416346          DOI: 10.1128/JVI.00563-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection.

Authors:  Sarah E Belisle; Jennifer R Tisoncik; Marcus J Korth; Victoria S Carter; Sean C Proll; David E Swayne; Mary Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

Authors:  A M LeVine; J A Whitsett; K L Hartshorn; E C Crouch; T R Korfhagen
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

3.  Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

Authors:  Jessica A Belser; Debra A Wadford; Claudia Pappas; Kortney M Gustin; Taronna R Maines; Melissa B Pearce; Hui Zeng; David E Swayne; Mary Pantin-Jackwood; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs.

Authors:  Wenjun Ma; Sarah E Belisle; Derek Mosier; Xi Li; Evelyn Stigger-Rosser; Qinfang Liu; Chuanling Qiao; Jake Elder; Richard Webby; Michael G Katze; Juergen A Richt
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

5.  Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?

Authors:  Jianqiang Ye; Erin M Sorrell; Yibin Cai; Hongxia Shao; Kemin Xu; Lindomar Pena; Danielle Hickman; Haichen Song; Matthew Angel; Rafael A Medina; Balaji Manicassamy; Adolfo Garcia-Sastre; Daniel R Perez
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

6.  Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome.

Authors:  Mirco Schmolke; Dorothee Viemann; Johannes Roth; Stephan Ludwig
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

7.  Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus.

Authors:  T Horimoto; Y Kawaoka
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells.

Authors:  Hui Zeng; Cynthia Goldsmith; Pranee Thawatsupha; Malinee Chittaganpitch; Sunthareeya Waicharoen; Sherif Zaki; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.

Authors:  Kaifeng Lisa Lin; Yasushi Suzuki; Hideki Nakano; Elizabeth Ramsburg; Michael Dee Gunn
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

10.  Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.

Authors:  John C Kash; Kathie-Anne Walters; A Sally Davis; Aline Sandouk; Louis M Schwartzman; Brett W Jagger; Daniel S Chertow; Qi Li; Rolf E Kuestner; Adrian Ozinsky; Jeffery K Taubenberger
Journal:  mBio       Date:  2011-09-20       Impact factor: 7.867

View more
  32 in total

1.  Quantitative modeling of virus evolutionary dynamics and adaptation in serial passages using empirically inferred fitness landscapes.

Authors:  Hyung Jun Woo; Jaques Reifman
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

2.  A comprehensive collection of systems biology data characterizing the host response to viral infection.

Authors:  Brian D Aevermann; Brett E Pickett; Sanjeev Kumar; Edward B Klem; Sudhakar Agnihothram; Peter S Askovich; Armand Bankhead; Meagen Bolles; Victoria Carter; Jean Chang; Therese R W Clauss; Pradyot Dash; Alan H Diercks; Amie J Eisfeld; Amy Ellis; Shufang Fan; Martin T Ferris; Lisa E Gralinski; Richard R Green; Marina A Gritsenko; Masato Hatta; Robert A Heegel; Jon M Jacobs; Sophia Jeng; Laurence Josset; Shari M Kaiser; Sara Kelly; G Lynn Law; Chengjun Li; Jiangning Li; Casey Long; Maria L Luna; Melissa Matzke; Jason McDermott; Vineet Menachery; Thomas O Metz; Hugh Mitchell; Matthew E Monroe; Garnet Navarro; Gabriele Neumann; Rebecca L Podyminogin; Samuel O Purvine; Carrie M Rosenberger; Catherine J Sanders; Athena A Schepmoes; Anil K Shukla; Amy Sims; Pavel Sova; Vincent C Tam; Nicolas Tchitchek; Paul G Thomas; Susan C Tilton; Allison Totura; Jing Wang; Bobbie-Jo Webb-Robertson; Ji Wen; Jeffrey M Weiss; Feng Yang; Boyd Yount; Qibin Zhang; Shannon McWeeney; Richard D Smith; Katrina M Waters; Yoshihiro Kawaoka; Ralph Baric; Alan Aderem; Michael G Katze; Richard H Scheuermann
Journal:  Sci Data       Date:  2014-10-14       Impact factor: 6.444

3.  Development of Novel Anti-influenza Thiazolides with Relatively Broad-Spectrum Antiviral Potentials.

Authors:  Lei Zhao; Yunzheng Yan; Qingsong Dai; Xingzhou Li; Ke Xu; Gang Zou; Keyu Yang; Wei Li; Xiaojia Guo; Jingjing Yang; Yuexiang Li; Qing Xia; Ruiyuan Cao; Wu Zhong
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

4.  PTN signaling: Components and mechanistic insights in human ovarian cancer.

Authors:  Geetika Sethi; Youngjoo Kwon; Rebecca J Burkhalter; Harsh B Pathak; Rashna Madan; Sarah McHugh; Safinur Atay; Smruthi Murthy; Ossama W Tawfik; Andrew K Godwin
Journal:  Mol Carcinog       Date:  2014-11-21       Impact factor: 4.784

5.  The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Qingqing Song; Min Gu; Xiaowen Liu; Xiaoquan Wang; Shunlin Hu; Chaoyang Chen; Huimou Liu; Wenbo Liu; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

6.  The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.

Authors:  Adriana Forero; Jennifer Tisoncik-Go; Tokiko Watanabe; Gongxun Zhong; Masato Hatta; Nicolas Tchitchek; Christian Selinger; Jean Chang; Kristi Barker; Juliet Morrison; Jason D Berndt; Randall T Moon; Laurence Josset; Yoshihiro Kawaoka; Michael G Katze
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.

Authors:  Juliet Morrison; Laurence Josset; Nicolas Tchitchek; Jean Chang; Jessica A Belser; David E Swayne; Mary J Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

8.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

Review 9.  Molecular determinants of influenza virus pathogenesis in mice.

Authors:  Ram P Kamal; Jaqueline M Katz; Ian A York
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

10.  Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling.

Authors:  Amy C Graham; Kimberly M Hilmer; Julianne M Zickovich; Joshua J Obar
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.